326 related articles for article (PubMed ID: 17916442)
1. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.
Boasso A; Shearer GM
Clin Immunol; 2008 Mar; 126(3):235-42. PubMed ID: 17916442
[TBL] [Abstract][Full Text] [Related]
2. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice.
Li G; Cheng M; Nunoya J; Cheng L; Guo H; Yu H; Liu YJ; Su L; Zhang L
PLoS Pathog; 2014 Jul; 10(7):e1004291. PubMed ID: 25077616
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline.
Drewes JL; Szeto GL; Engle EL; Liao Z; Shearer GM; Zink MC; Graham DR
PLoS One; 2014; 9(4):e94375. PubMed ID: 24732038
[TBL] [Abstract][Full Text] [Related]
4. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
Gonzalez VD; Landay AL; Sandberg JK
Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
[TBL] [Abstract][Full Text] [Related]
5. The involvement of plasmacytoid cells in HIV infection and pathogenesis.
Aiello A; Giannessi F; Percario ZA; Affabris E
Cytokine Growth Factor Rev; 2018 Apr; 40():77-89. PubMed ID: 29588163
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.
Fitzgerald-Bocarsly P; Jacobs ES
J Leukoc Biol; 2010 Apr; 87(4):609-20. PubMed ID: 20145197
[TBL] [Abstract][Full Text] [Related]
7. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
Schmidt B; Ashlock BM; Foster H; Fujimura SH; Levy JA
Virology; 2005 Dec; 343(2):256-66. PubMed ID: 16278001
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers.
Herbeuval JP; Smith N; Thèze J
Clin Dev Immunol; 2012; 2012():869505. PubMed ID: 23243424
[TBL] [Abstract][Full Text] [Related]
9. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.
Manches O; Munn D; Fallahi A; Lifson J; Chaperot L; Plumas J; Bhardwaj N
J Clin Invest; 2008 Oct; 118(10):3431-9. PubMed ID: 18776940
[TBL] [Abstract][Full Text] [Related]
10. Role for plasmacytoid dendritic cells in anti-HIV innate immunity.
Müller-Trutwin M; Hosmalin A
Immunol Cell Biol; 2005 Oct; 83(5):578-83. PubMed ID: 16174110
[TBL] [Abstract][Full Text] [Related]
11. Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.
Boasso A; Royle CM; Doumazos S; Aquino VN; Biasin M; Piacentini L; Tavano B; Fuchs D; Mazzotta F; Lo Caputo S; Shearer GM; Clerici M; Graham DR
Blood; 2011 Nov; 118(19):5152-62. PubMed ID: 21931112
[TBL] [Abstract][Full Text] [Related]
12. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
13. Disruption of Type I Interferon Induction by HIV Infection of T Cells.
Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G
PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
[TBL] [Abstract][Full Text] [Related]
15. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation.
Zhang Z; Xu X; Lu J; Zhang S; Gu L; Fu J; Jin L; Li H; Zhao M; Zhang J; Wu H; Su L; Fu YX; Wang FS
J Infect Dis; 2011 Jun; 203(11):1668-78. PubMed ID: 21592997
[TBL] [Abstract][Full Text] [Related]
16. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells.
Tomescu C; Chehimi J; Maino VC; Montaner LJ
J Immunol; 2007 Aug; 179(4):2097-104. PubMed ID: 17675468
[TBL] [Abstract][Full Text] [Related]
17. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells.
Manel N; Hogstad B; Wang Y; Levy DE; Unutmaz D; Littman DR
Nature; 2010 Sep; 467(7312):214-7. PubMed ID: 20829794
[TBL] [Abstract][Full Text] [Related]
18. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
[TBL] [Abstract][Full Text] [Related]
20. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
